Enrique Sanhueza

Dr. Enrique Sanhueza

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2016 in Journal of Medical Microbiology
Verified
Journal Article
Closed access
VGValeria García-Castillo
Valeria García-Castillo
Enrique SanhuezaEnrique Sanhueza
Enrique Sanhueza
EMEileen McNerney
Eileen McNerney
SOSergio A. Onate
Sergio A. Onate
ACApolinaria Garcia Cancino
Apolinaria Garcia Cancino
Cancer is defined as an uncontrolled proliferation of malignant cells in a host and it is one of the main causes of death worldwide. Genetic and environmental factors play an important role in its development, and the involvement of microbial communities has also recently been recognized. The close relationship that characterizes the colonization by human commensal communities involves health risks, particularly when the homeostasis is disturbed. It has been hypothesized that this process may lead to cancer by modulating the inflammatory response of the host, by the production of carcinogenic metabolic products or by the production of toxins, which disrupt the cell cycle. The metabolic effects of the intestinal microbiota have been studied in greater detail in the gastrointestinal tract, and it has been recognized that microbial communities of other body surfaces can cause effects either locally or at a distance. In vitro and in vivo studies have allowed the characterization of the microbiota and the establishment of a cause and effect relationship with some types of cancer. Nevertheless, despite the results, representative studies are necessary to validate the findings and definitively establish the role of microbiota in cancer development in order to open the possibility of promising therapeutic and diagnostic applications. Thus, the aims of this review are to briefly examine the available evidence, and to analyse the mechanisms described for pancreatic, lung, colorectal cancer , oral squamous cell carcinoma and hepatocellular carcinoma and the impact of the current knowledge about the effects of the microbiota on carcinogenesis.

1 January 2017 in Electronic Journal of Biotechnology
Verified
Journal Article
Open access
AGApolinaria García
Apolinaria García
KNKaren Navarro
Karen Navarro
Enrique SanhuezaEnrique Sanhueza
Enrique Sanhueza
SPSusana Pineda
Susana Pineda
EPEdgar Pastene
Edgar Pastene
CGCarlos González
Carlos González
Background: Helicobacter pylori is considered as the main risk factor in the development of gastric cancer. In the present study, we performed a detailed characterization of the probiotic properties and the anti-H. pylori activity of a previously isolated lactobacillus strain — Lactobacillus fermentum UCO-979C — obtained from human gut. Results: The strain tolerated pH 3.0; grew in the presence of 2% bile salts; produced lactic acid and hydrogen peroxide; aggregated in saline solution; showed high hydrophobicity; showed high adherence to glass; Caco-2 and gastric adenocarcinoma human cells (AGS) cells; showed an efficient colonization in Mongolian Gerbils; and potently inhibited the growth and urease activity of H. pylori strains. L. fermentum UCO-979C significantly inhibited H. pylori-induced IL-8 production in AGS cells and reduced the viability of H. pylori. With regard to innocuousness, the strain UCO-979C was susceptible to several antibiotics and did not produce histamine or beta-haemolysis in blood agar containing red blood cells from various origins. Conclusion: The results demonstrated that L. fermentum UCO-979C is a very good candidate as a probiotic for the protection of humans against H. pylori infections

11 November 2016 in Biofouling
Verified
Journal Article
Closed access
MSM. J. Salas-Jara
M. J. Salas-Jara
Enrique SanhuezaEnrique Sanhueza
Enrique Sanhueza
ARA. Retamal-Díaz
A. Retamal-Díaz
CGC. González
C. González
HUH. Urrutia
H. Urrutia
ACApolinaria Garcia Cancino
Apolinaria Garcia Cancino
The ability of the human isolate Lactobacillus fermentum UCO-979C to form biofilm and synthesize exopolysaccharide on abiotic and biotic models is described. These properties were compared with the well-known Lactobacillus casei Shirota to better understand their anti-Helicobacter pylori probiotic activities. The two strains of lactobacilli synthesized exopolysaccharide as detected by the Dubois method and formed biofilm on abiotic and biotic surfaces visualized by crystal violet staining and scanning electron microscopy. Concomitantly, these strains inhibited H. pylori urease activity by up to 80.4% (strain UCO-979C) and 66.8% (strain Shirota) in gastric adenocarcinoma (AGS) cells, but the two species showed equal levels of inhibition (~84%) in colorectal adenocarcinoma (Caco-2) cells. The results suggest that L. fermentum UCO-979C has probiotic potential against H. pylori infections. However, further analyses are needed to explain the increased activity observed against the pathogen in AGS cells as compared to L. casei Shirota.

1 September 2015 in Electronic Journal of Biotechnology
Verified
Journal Article
Open access
Enrique SanhuezaEnrique Sanhueza
Enrique Sanhueza
EPEsteban Paredes-Osses
Esteban Paredes-Osses
CGCarlos L. González
Carlos L. González
AGApolinaria García
Apolinaria García
BackgroundBacterial acclimation involves cellular changes permitting the survival of a microorganism to prolonged acid pH exposure. The general aim of this work is to support this idea by determining the effect of pH in the survival of the human gastric derived probiotic strain Lactobacillus salivarius UCO_979C-1 (wild type) and L. salivarius UCO_979C-2 (acclimation to pH2.6), which possesses anti-Helicobacter pylori properties.ResultsTo assess this aim, the exopolysaccharide production through the phenol-sulfuric acid method was evaluated. Moreover, morphological and structural changes by transmission and scanning electron microscopy were observed. The bacterial survival was measured by viable count. The results showed that the acclimated variant strain synthesized higher levels of exopolysaccharide (690±0.03mg/L) more than the wild type (450±0.12mg/L). In addition, the acclimated variant preserved the viable count at pH2.6 for 48h, whereas the wild type strain decreases after 6h and was non-viable at 24h.ConclusionThe results suggest that the acid stress acclimation of the strain L. salivarius UCO_979C-1 modified some cellular properties making this strain potentially useful as a gastric probiotic

11 March 2017 in Folia Microbiologica
Verified
Journal Article
Closed access
PDF file
EPEsteban Paredes-Osses
Esteban Paredes-Osses
KSKatia Sáez
Katia Sáez
Enrique SanhuezaEnrique Sanhueza
Enrique Sanhueza
SHSonja Hebel
Sonja Hebel
CGCarlos González
Carlos González
ACApolinaria Garcia Cancino
Apolinaria Garcia Cancino

29 June 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
Enrique SanhuezaEnrique Sanhueza
Enrique Sanhueza
CRCassiopeia Cantero Ramírez
Cassiopeia Cantero Ramírez
AVAngel David Montijo Valdés
Angel David Montijo Valdés
CVCinthya Guadalupe Rodríguez Valladeres
Cinthya Guadalupe Rodríguez Valladeres
Cynthia Fernandez-LainezCynthia Fernandez-Lainez
Cynthia Fernandez-Lainez
Gabriel López-VelázquezGabriel López-Velázquez
Gabriel López-Velázquez
Cardiovascular diseases (CVDs) have become one of the major global health crises of the last century, causing millions of deaths each year, and are the leading cause of disability worldwide. The pharmacological management of these conditions demands new alternative or complementary therapies due to the multiple long-term side effects experienced by patients. In this context, exopolysaccharides (EPSs) have emerged as a promising alternative due to their numerous functional properties and favorable biotechnological and medical applications for health. This review provides an overview of the properties of EPSs as bioactive agents in cardiovascular diseases, highlighting the cellular signaling mechanisms in their role as cardioprotective agents, with a primary focus on their roles as antioxidants, antihypertensives, and cholesterol regulators, and their regenerative effects on vascular epithelia, positioning EPSs as promising biomolecules for CVD prevention.